Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
Laurent Arnaud(Université Libre de Bruxelles), Zahir Amoura(Inserm), Alexis Mathian(Inserm), Vittorio Pengo(University of Padua), Guillaume Lefèvre(Université de Lille), Juan Balasch(Universitat Autònoma de Barcelona), Ricardo Forastiero(Favaloro University), Maria G. Tektonidou(National and Kapodistrian University of Athens), Amelia Ruffatti(University of Padua), H. Devilliers(CHU Dijon Bourgogne), Maria Ángeles Martínez‐Zamora(Hospital Clínic de Barcelona), M. Lambert(Hôpital Claude Huriez), Denis Wahl(Inserm)
Cited by 146
Related Papers
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
The immune paradox of sarcoidosis and regulatory T cells
|The Journal of Experimental Medicine|2006|444
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414